OPIA Technologies Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $3.33M
Latest Deal Amount
  • Investors
  • 2

OPIA Technologies General Information

Description

Developer of medical devices in particular ocular surface sampling devices designed for diagnostic purposes. The company's services offer a technology platform for in vivo biopsies of the conjunctiva for further analysis to help diagnose the most common ocular surface disorders such as dry eye, allergies, or blepharitis, enabling clients in the healthcare sector to provide innovative and reliable devices to improve the diagnosis and care of patients with ocular diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • 17, Rue Moreau
  • 75012 Paris
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OPIA Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 03-Mar-2014 $3.33M 00.000 000.00 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view OPIA Technologies’s complete valuation and funding history, request access »

OPIA Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
To view OPIA Technologies’s complete cap table history, request access »

OPIA Technologies Patents

OPIA Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160354239-A1 Ocular iontophoresis device Granted 27-Jan-2014 0000000000 0
CA-2937929-A1 Ocular iontophoresis device Abandoned 27-Jan-2014 0000000000
ES-2672327-T3 Eye iontophoresis device Active 27-Jan-2014 0000000000
US-10478333-B2 Ocular iontophoresis device Active 27-Jan-2014 0000000000 00
EP-2898922-B1 Ocular iontophoresis device Active 27-Jan-2014 A61F9/0017
To view OPIA Technologies’s complete patent history, request access »

OPIA Technologies Executive Team (1)

Name Title Board Seat Contact Info
Pierre Roy Co-Founder, Chief Executive Officer & President
To view OPIA Technologies’s complete executive team members history, request access »

OPIA Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OPIA Technologies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agoranov Accelerator/Incubator 000 0000 000000 0
Incubateur Insitut de La Vision Accelerator/Incubator Minority 000 0000 000000 0
To view OPIA Technologies’s complete investors history, request access »